Judge Blocks Biden Admin Changes to Vaccine Schedules, Cites Unqualified ACIP Members

A federal judge has blocked significant changes to the U.S. Childhood immunization schedule and halted the appointment of new members to the Advisory Committee on Immunization Practices (ACIP), a key advisory body to the Centers for Disease Control and Prevention (CDC). The ruling, issued by Judge Brian Murphy of the U.S. District Court for the District of Massachusetts, represents a major setback for the Biden administration’s efforts, led by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., to overhaul vaccine policy. The core of the dispute centers on accusations that the administration bypassed established scientific procedures and disregarded expert advice in favor of politically motivated changes.

Procedural Failures at the Heart of the Dispute

Judge Murphy’s decision, detailed in a court document, centers on the argument that the HHS under Kennedy Jr. Circumvented longstanding, evidence-based procedures traditionally used to develop national vaccine guidance. The judge specifically criticized the administration’s decision to revise the immunization schedule without proper consultation with ACIP, a committee designed to provide independent, scientifically grounded recommendations. “This is all to say that there is a method to how these decisions historically have been made—a method scientific in nature and codified into law through procedural requirements,” Judge Murphy wrote. He further argued that the abrupt replacement of experienced ACIP members with individuals lacking relevant expertise undermined the integrity of the process.

The lawsuit, AAP et. Al. V Kennedy et. Al., was brought by a coalition of medical and public health organizations, including the American Academy of Pediatrics, the American Public Health Association, and the Infectious Diseases Society of America. These groups alleged that the changes were not based on scientific evidence and would jeopardize public health. The American Public Health Association (APHA) welcomed the court’s decision, stating it blocks “non–evidence-based changes to established vaccine schedules.”

Questionable Qualifications of ACIP Appointments

The judge’s ruling didn’t stop at criticizing the process; it as well directly questioned the qualifications of the individuals appointed to ACIP by Secretary Kennedy Jr. The court document specifically names several members who appear to lack the necessary expertise in vaccines or immunization. According to the ruling, at least six of the fifteen current ACIP members – Dr. Hillary Blackburn, Dr. Evelyn Griffin, Dr. Joseph Hibbeln, Dr. Kirk Milhoan, Dr. James Pagano, and Dr. Raymond Pollak – “appear to lack any expertise or professional qualifications related to vaccines or immunization.” An additional three – Dr. Retsef Levi, Dr. Robert Malone, and Dr. Catherine Stein – were cited as having limited relevant experience. The ACIP charter requires members to possess knowledge in relevant fields, and federal regulations mandate that advisory boards be “fairly balanced” in representing diverse viewpoints within those fields. Politico reports that Judge Murphy stopped short of formally blocking the appointments, but stayed them pending further review.

What Was Changed, and Why?

The changes blocked by the court included a heavily revised vaccine schedule issued by HHS on January 5th, the overturning of a May 2025 Secretarial Directive on COVID-19 vaccine recommendations, and the reversal of downgraded Hepatitis B vaccine recommendations made at the December 2025 ACIP meeting. These changes, widely seen as aligning with Kennedy Jr.’s long-held skepticism towards vaccines, sparked immediate controversy within the medical community. Kennedy Jr., a prominent figure in the anti-vaccine movement, has repeatedly questioned the safety and efficacy of vaccines, despite overwhelming scientific consensus to the contrary. CIDRAP reports that the judge’s decision halts these changes while the legal challenge proceeds.

Understanding the Advisory Committee on Immunization Practices (ACIP)

The ACIP is a crucial component of the U.S. Vaccine program. Established in 1961, We see a panel of medical and public health experts that advises the CDC on which vaccines are recommended for use in the United States. ACIP recommendations are based on a rigorous review of scientific evidence, and they play a vital role in shaping national immunization policy. The committee’s recommendations are not legally binding, but they are almost always adopted by the CDC and subsequently influence vaccination guidelines for healthcare providers and the public.

Implications for Public Health and Trust

The judge’s injunction has significant implications for public health. By halting the implementation of the revised vaccine schedule, the ruling preserves the existing, evidence-based recommendations that have been credited with preventing countless cases of infectious diseases. However, the controversy surrounding the changes and the legal challenge itself could further erode public trust in vaccines and immunization programs. This is particularly concerning given the ongoing efforts to combat vaccine hesitancy and misinformation. The lawsuit argues that the actions taken by HHS undermine public health, disrupt clinical practice, and erode confidence in immunization policy.

The Federal Advisory Committee Act (FACA)

A key element of the legal challenge revolves around the Federal Advisory Committee Act (FACA). FACA governs the establishment and operation of advisory committees used by the federal government. It requires that these committees be transparent, balanced, and operate according to established procedures. The plaintiffs in the lawsuit argue that Secretary Kennedy Jr.’s actions violated FACA by bypassing ACIP, failing to adequately vet new members, and appointing individuals lacking the necessary expertise.

What Comes Next: Procedural Review and Ongoing Litigation

The court has allowed the underlying lawsuit to proceed, denying the government’s motion to dismiss. In other words that the plaintiffs will have the opportunity to present evidence supporting their claims that the HHS actions were unlawful and detrimental to public health. The case will now move forward with discovery and potential trial. The preliminary injunction remains in effect until the court reaches a final decision on the merits of the case. The Biden administration has not yet indicated whether it will appeal the injunction, but it is likely to vigorously defend its actions in court. The outcome of this litigation will have a lasting impact on the future of vaccine policy in the United States and the role of scientific expertise in government decision-making.